Sign In
Pricing

2022
Exports $46.8BWorld Rnk 3 / 208
Flag Rnk 6 / 1217
2022
Destination $2.28B China
2021 - 2022
FASTEST GROWING MARKET $2.28BSwitzerland
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures1.38Rnk 75 / 1025
2022
Imports $69.9BWorld Rnk 1 / 225
Flag Rnk 8 / 1216
2022
Origin $9.43B Ireland
2021 - 2022
FASTEST GROWING ORIGIN $9.43BSwitzerland
2022
ECONOMIC COMPLEXITY of United States1.47Rnk 10 / 133

About

Exports In 2022, United States exported $46.8B in Vaccines, blood, antisera, toxins and cultures, making it the 3rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most exported product in United States. The main destination of Vaccines, blood, antisera, toxins and cultures exports from United States are: China ($5.83B), Germany ($4.97B), Netherlands ($3.74B), Switzerland ($3.62B), and Canada ($3.24B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of United States between 2021 and 2022 were Switzerland ($2.28B), China ($2.03B), and Netherlands ($754M).

Imports In 2022, United States imported $69.9B in Vaccines, blood, antisera, toxins and cultures, becoming the 1st largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in United States. United States imports Vaccines, blood, antisera, toxins and cultures primarily from: Ireland ($17.8B), Switzerland ($14.2B), Belgium ($9.38B), Germany ($9.2B), and Italy ($2.66B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for United States between 2021 and 2022 were Switzerland ($9.43B), Belgium ($2.29B), and Ireland ($1.56B).

COMPANIES In 2023, leading companies such as Amazon (6), Tesla (5), and Costco Wholesale (2) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures to the United States.

Latest Trends

September 2024

About

Overview In September 2024 United States' Vaccines, blood, antisera, toxins and cultures exports accounted up to $4.43B and imports accounted up to $10.9B, resulting in a negative trade balance of $6.45B. Between September 2023 and September 2024 the exports of United States'   Vaccines, blood, antisera, toxins and cultures have increased by $253M (6.06%) from $4.17B to $4.43B, while imports increased by $3.98B (57.8%) from $6.89B to $10.9B.

Destinations In September 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to Germany ($645M), China ($566M), Ireland ($380M), Japan ($364M), and Netherlands ($325M), and were imported mostly from Ireland ($4.31B), Netherlands ($1.18B), Germany ($1B), Belgium ($873M), and Singapore ($625M).

Growth In September 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to Belgium ($771M or 391%), Netherlands ($272M or 132%), and China ($245M or 221%). In September 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Netherlands ($663M or 375%), Ireland ($572M or 41.4%), and Germany ($379M or 60.8%).

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (September 2023 - September 2024)$253M(6.06%)
IMPORT GROWTH (September 2023 - September 2024)$3.98B(57.8%)
MAIN EXPORTER (September 2024)Puerto Rico$1.76B
MAIN DESTINATION (September 2024)Germany$645M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$46.8B
IMPORTS (2022)$69.9B
NET TRADE (2022)-$23B

In 2022, United States exported $46.8B in Vaccines, blood, antisera, toxins and cultures. The main destinations of United States exports on Vaccines, blood, antisera, toxins and cultures were China ($5.83B), Germany ($4.97B), Netherlands ($3.74B), Switzerland ($3.62B), and Canada ($3.24B).

In 2022, United States imported $69.9B in Vaccines, blood, antisera, toxins and cultures, mainly from Ireland ($17.8B), Switzerland ($14.2B), Belgium ($9.38B), Germany ($9.2B), and Italy ($2.66B).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR United States WERE (2021 - 2022):
Switzerland$2.28B (170%)
China$2.03B (53.5%)
Netherlands$754M (25.3%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY United States WERE (2021 - 2022):
Brazil-$1.82B (-72.1%)
Belgium-$695M (-26.8%)
Philippines-$479M (-73%)
Explore Visualizations

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, United States's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
Ireland $47.3B
Belgium $47.1B
In 2022, United States's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:
Germany $36B
Belgium $20.7B

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALCanada+ $1.02B
TOP IMPORT POTENTIALSwitzerland+ $636M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is Canada. With an export gap of $1.02B.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Switzerland with an import gap of $636M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms